Furthermore, a previous case-control study (16) also reported that the SLC12A3-Arg913Gln variation could be used to predict the risk of ESRD in Chinese patients with type 2 diabetes. This evidence concerns the gene SLC12A3 and type 2 diabetes mellitus.